Clinical Trials Browser

Breast Neoplasms, Neoplasm Metastasis

NCT07528898 2026-04-14

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

Phase 2 Not yet recruiting

100 enrolled

Breast

Breast Neoplasms

NCT04943497 2026-04-01

PROSPERITY

Completed

2,424 enrolled

Breast

Breast Neoplasms

NCT05143970 2026-03-20

CHANCES

Phase 1 Recruiting

27 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Clinical Trials

ECLECTIC

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

PROSPERITY

CHANCES

Morpheus-panBC

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

FACT-TN

Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Néo-APBI-01

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes

NEOLBC

AVR-CHEMO

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

PTX / BC

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer

Arsenous Acid for Refractory Triple-Negative Breast Cancer

SENIOR

A Study on the Efficacy and Safety of IPyC for HER2+ MBC

SPORTNATHy